Jean E. Surfus

871 total citations
20 papers, 699 citations indexed

About

Jean E. Surfus is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Jean E. Surfus has authored 20 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Jean E. Surfus's work include Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and CAR-T cell therapy research (6 papers). Jean E. Surfus is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and CAR-T cell therapy research (6 papers). Jean E. Surfus collaborates with scholars based in United States. Jean E. Surfus's co-authors include Paul M. Sondel, Jacquelyn A. Hank, Ralph A. Reisfeld, Stephen D. Gillies, Paul M. Sondel, Barbara M. Mueller, N K Cheung, Jacek Gan, Randy Robinson and Mark R. Albertini and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Jean E. Surfus

20 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean E. Surfus United States 13 396 318 231 216 172 20 699
NK Cheung United States 9 229 0.6× 168 0.5× 157 0.7× 200 0.9× 95 0.6× 13 597
R. Handgretinger Germany 15 226 0.6× 222 0.7× 286 1.2× 228 1.1× 65 0.4× 33 718
Ilia N. Buhtoiarov United States 15 614 1.6× 409 1.3× 102 0.4× 164 0.8× 100 0.6× 30 812
A. Knuth Germany 12 536 1.4× 344 1.1× 50 0.2× 256 1.2× 107 0.6× 33 816
Nicolas Leupin Switzerland 11 174 0.4× 132 0.4× 151 0.7× 205 0.9× 148 0.9× 29 730
K Cechova United States 7 284 0.7× 363 1.1× 58 0.3× 309 1.4× 41 0.2× 9 848
Ming-Sheng Lee United States 8 242 0.6× 445 1.4× 63 0.3× 209 1.0× 45 0.3× 10 1.0k
Rosita L. ten Berge Netherlands 12 235 0.6× 281 0.9× 89 0.4× 180 0.8× 20 0.1× 18 717
MK Brenner United Kingdom 10 310 0.8× 213 0.7× 87 0.4× 174 0.8× 29 0.2× 16 723
Anne Bastian United States 10 552 1.4× 509 1.6× 35 0.2× 265 1.2× 54 0.3× 12 895

Countries citing papers authored by Jean E. Surfus

Since Specialization
Citations

This map shows the geographic impact of Jean E. Surfus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean E. Surfus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean E. Surfus more than expected).

Fields of papers citing papers by Jean E. Surfus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean E. Surfus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean E. Surfus. The network helps show where Jean E. Surfus may publish in the future.

Co-authorship network of co-authors of Jean E. Surfus

This figure shows the co-authorship network connecting the top 25 collaborators of Jean E. Surfus. A scholar is included among the top collaborators of Jean E. Surfus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean E. Surfus. Jean E. Surfus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
King, David M., Mark R. Albertini, Heidi Schalch, et al.. (2004). Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients. Journal of Clinical Oncology. 22(22). 4463–4473. 114 indexed citations
2.
Neal, Zane C., Michael Imboden, Alexander L. Rakhmilevich, et al.. (2003). NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy. Cancer Immunology Immunotherapy. 53(1). 41–52. 37 indexed citations
3.
Hank, Jacquelyn A., et al.. (2003). Determination of Peak Serum Levels and Immune Response to the Humanized Anti-Ganglioside Antibody-Interleukin-2 Immunocytokine. Humana Press eBooks. 85. 123–132. 10 indexed citations
4.
Kendra, Kari, Jacek Gan, Jean E. Surfus, et al.. (1999). Pharmacokinetics and stability of the ch14.18-interleukin-2 fusion protein in mice. Cancer Immunology Immunotherapy. 48(5). 219–229. 37 indexed citations
5.
Hank, J A, Jean E. Surfus, Mark R. Albertini, et al.. (1999). Distinct clinical and laboratory activity of two recombinant interleukin-2 preparations.. PubMed. 5(2). 281–9. 23 indexed citations
6.
Nicolet, Charles M., et al.. (1997). TAG-72-Reactive Antibody CC49 Recognizes Molecules Expressed by Hematopoietic Cell Lines. Tumor Biology. 18(6). 356–366. 8 indexed citations
7.
Surfus, Jean E., Jacquelyn A. Hank, Egbert Oosterwijk, et al.. (1996). Anti-Renal-Cell Carcinoma Chimeric Antibody G250 Facilitates Antibody-Dependent Cellular Cytotoxicity with In Vitro and In Vivo Interleukin-2-Activated Effectors. Journal of Immunotherapy. 19(3). 184–191. 50 indexed citations
8.
Hank, J A, Jean E. Surfus, Jing Gan, et al.. (1996). ACTIVATION OF HUMAN EFFECTOR CELLS BY A TUMOR REACTIVE RECOMBINANT ANTI-GANGLIOSIDE GD2 INTERLEUKIN-2 FUSION PROTEIN. Journal of Immunotherapy. 19(6). 463–463. 6 indexed citations
9.
Albertini, Mark R., Jacek Gan, Barry E. Storer, et al.. (1996). Systemic Interleukin-2 Modulates the Anti-Idiotypic Response to Chimeric Anti-GD2 Antibody in Patients with Melanoma. Journal of Immunotherapy. 19(4). 278–295. 24 indexed citations
10.
Hank, Jacquelyn A., et al.. (1996). Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).. PubMed. 2(12). 1951–9. 61 indexed citations
11.
Hank, Jacquelyn A., Jean E. Surfus, Jacek Gan, et al.. (1994). Treatment of Neuroblastoma Patients with Antiganglioside GD2 Antibody plus Interleukin-2 Induces Antibody-Dependent Cellular Cytotoxicity Against Neuroblastoma Detected In Vitro. Journal of Immunotherapy. 15(1). 29–37. 56 indexed citations
12.
Fisch, Paul, et al.. (1992). MHC-unrestricted cytotoxic and proliferative responses of two distinct human γ/δ T cell subsets to Daudi cells. The Journal of Immunology. 148(8). 2315–2323. 66 indexed citations
13.
Hank, Jacquelyn A., G Weil-Hillman, Jean E. Surfus, Jeffrey A. Sosman, & Paul M. Sondel. (1990). Addition of interleukin-2in vitro augments detection of lymphokine-activated killer activity generatedin vivo. Cancer Immunology Immunotherapy. 31(1). 53–59. 23 indexed citations
14.
Hank, Jacquelyn A., Randy Robinson, Jean E. Surfus, et al.. (1990). Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2.. PubMed. 50(17). 5234–9. 130 indexed citations
15.
Trigg, ME, Alan C. Peterson, Marek J. Bozdech, et al.. (1986). Depletion of T cells from bone marrow for allogeneic transplantation: method for treatment of bone marrow in bulk.. PubMed. 14(1). 21–6. 16 indexed citations
16.
Flaherty, Dennis K., Mauro Geller, Jean E. Surfus, et al.. (1980). HLA antigen frequencies and natural history in Alternaria-sensitive and perennial nonallergic asthmatics. Journal of Allergy and Clinical Immunology. 66(5). 408–416. 6 indexed citations
17.
Flaherty, Dennis K., Jean Martin, Jean E. Surfus, Joshua Kooistra, & C.E. Reed. (1978). Antibody-dependent cellular cytotoxicity of mononuclear cells from asthmatics tested in three in vitro assays. Journal of Allergy and Clinical Immunology. 62(3). 156–161. 1 indexed citations
18.
Flaherty, Dennis K., Jean E. Surfus, Mauro Geller, et al.. (1978). HLA antigen frequencies in allergic bronchopulmonary aspergillosis. Clinical & Experimental Allergy. 8(1). 73–76. 8 indexed citations
19.
Flaherty, Dennis K., et al.. (1977). Antibody-dependent cellular cytotoxicity in asthmatics. Journal of Allergy and Clinical Immunology. 59(1). 48–53. 12 indexed citations
20.
Flaherty, Dennis K., Jean E. Surfus, Annette Bryant, et al.. (1976). Lymphocyte subpopulations in the peripheral blood of patients with farmer's lung.. PubMed. 114(6). 1093–8. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026